| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 333,349 | 236,406 | 90,207 | | Cost of Revenue | 88,614 | 65,924 | 30,152 | | | Gross Profit | 244,735 | 170,482 | 60,055 | | | Operating Expenses | | Research Development | 58,658 | 39,696 | 19,215 | | Selling General and Administrative | 190,322 | 120,486 | 57,374 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,245) | 10,300 | (16,534) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,514 | 9,733 | 1,239 | | Earnings Before Interest And Taxes | 2,269 | 20,033 | (15,295) | | Interest Expense |
-
|
-
| 247 | | Income Before Tax | 2,269 | 20,033 | (15,542) | | Income Tax Expense | (8,332) | 5,235 | 303 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,601 | 14,798 | (15,845) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 10,601 | 14,798 | (15,845) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,601 | $14,798 | ($15,845) |
|
0.34% Nasdaq 0.00%
Income Statement
